From GlobeNewswire:

Medicenna Therapeutics Corp. appoints MNP LLP as its new auditor following the resignation of PricewaterhouseCooper LLP. The former auditor issued no modified opinions or reservations for the two most recently completed financial years and after that. Tandem Accounting Group Ltd. has also been engaged by Medicenna to handle financial reporting and internal bookkeeping. Medicenna is focused on developing highly selective versions of IL-2, IL-4, and IL-13 Superkines. Medicenna also confirmed that there are no “reportable events” in connection with the former auditor’s audits. The announcements have been filed on SEDAR. The reader is cautioned not to place undue reliance on any forward-looking information. Any forward-looking information may differ from those anticipated.JNIEXPORT

To stay updated about Medicenna, please visit www.medicenna.com and follow them on Twitter and LinkedIn. wpghACHER

The reader is cautioned that forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date hereof and except as required by law, we do not intend and do not assume any obligation to update or revise publicly any of the included forward-looking statements.



Read more: Medicenna Announces Appointment of New Auditor